Association of HRCT severity score, pre-existing comorbidities, and ABO blood group with treatment outcomes of COVID-19 patients admitted in a hospital of Western Nepal

Authors

  • Dipesh Karki Consultant Physician, Department of Medicine, Fishtail Hospital and Research Center Private Limited, Pokhara, Kaski, Nepal https://orcid.org/0000-0002-4789-8765
  • Saksham K C Medical Officer, Department of Medicine, Fishtail Hospital and Research Center Private Limited, Pokhara, Kaski, Nepal
  • Roshani Gurung Assistant Professor, Pharmacy Programme, Gandaki University, Pokhara, Kaski, Nepal https://orcid.org/0000-0003-2701-7227
  • Sundar Adhikari Head, Department of Pharmacy, Fishtail Hospital and Research Center Private Limited, Pokhara, Kaski, Nepal https://orcid.org/0000-0001-8501-0256

DOI:

https://doi.org/10.3126/ajms.v13i4.42468

Keywords:

ABO blood group, Coronavirus disease 2019, High-resolution computed tomography, Pre-existing comorbidities, Severity score, West Nepal

Abstract

Background: Although many studies have reported the association of different factors with the severity of coronavirus disease (COVID) patients, no concrete scientific conclusions have been reported till date.

Aim and Objective: This study aimed to conduct a prospective analysis on different factors associated with the severity and outcome of the COVID-19 patients.

Materials and Methods: The study was conducted in a 100-bedded hospital of West Nepal for 3 months, with the total number of hospitalized patients 78. Demographic data, pre-existing comorbidities, ABO blood group, high-resolution computed tomography (CT) severity score, and outcomes of the respondents were recorded and analyzed statistically using Chi-square, binomial regression test, and significance level was considered P<0.05 at 95% confidence intervals.

Results: Although the improvement rate was higher among males (84.0%) than females (75.0%), no significant association was observed between sex of the patient and treatment outcomes. Similarly, no significant association was observed in between age and ABO blood grouping of patients and treatment outcome. Furthermore, the chance of improvement is about 6 times higher (OR-6.214, 95% CI: 1.452–26.599; P=0.014) among patients with single comorbidity compared with patients with two or more comorbidities. Moreover, the chance of improvement is 8 times higher (OR-8, 95% CI: 2.034–31.461; P=0.001) in patients with CT severity score 1–15 compared with patients with CT severity score 16–25.

Conclusion: CT severity score and pre-existing comorbid conditions play an important role among the different associated factors with the severity and treatment outcomes of COVID-19 patients.

Downloads

Download data is not yet available.
Abstract
185
PDF
204

Downloads

Published

2022-04-01

How to Cite

Dipesh Karki, Saksham K C, Roshani Gurung, & Adhikari, S. (2022). Association of HRCT severity score, pre-existing comorbidities, and ABO blood group with treatment outcomes of COVID-19 patients admitted in a hospital of Western Nepal. Asian Journal of Medical Sciences, 13(4), 1–6. https://doi.org/10.3126/ajms.v13i4.42468

Issue

Vol. 13 No. 4 (2022)

Section

Original Articles

License

Copyright (c) 2022 Asian Journal of Medical Sciences

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

Authors who publish with this journal agree to the following terms:

  1. The journal holds copyright and publishes the work under a Creative Commons CC-BY-NC license that permits use, distribution and reprduction in any medium, provided the original work is properly cited and is not used for commercial purposes. The journal should be recognised as the original publisher of this work.
  2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
  3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).